FLAREX
LOE Approachingfluorometholone acetate
NDAOPHTHALMICSUSPENSION/DROPS
Approved
Feb 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
FLAREX (fluorometholone acetate) is clinical pharmacology corticosteroids suppress the inflammatory response to inciting agents of mechanical, chemical or immunological nature. First approved in 1986.
Drug data last refreshed 20h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLAREX (fluorometholone acetate) is a topical ophthalmic corticosteroid suspension approved in 1986 for treating inflammatory eye conditions. It suppresses the inflammatory response through corticosteroid mechanism of action and is administered as eye drops. The drug demonstrates a longer time to IOP elevation compared to dexamethasone, though ultimate magnitude of pressure rise is equivalent.
$0.004BPart D
LOE ApproachingDeclining
Product is approaching loss of exclusivity with moderate spend decline, suggesting a contracting brand team focused on retention strategy.
Mechanism of Action
CLINICAL PHARMACOLOGY Corticosteroids suppress the inflammatory response to inciting agents of mechanical, chemical or immunological nature. No generally accepted explanation of this steroid property has been advanced. Corticosteroids cause a rise in intraocular pressure (IOP) in susceptible…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FLAREX in its LOE phase offers limited career growth and team expansion; roles focus on managed decline, generic defense, and patient retention. This assignment is typically a holding or transitional position rather than a growth opportunity for ambitious pharma professionals.
Brand Manager
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.